NCT00419601View on ClinicalTrials.gov

Rapip Study: Clinical Trial on Remifentanyl for Analgesia and Sedation of Ventilated Neonates and Infants

PHASE3CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions

Mechanical Ventilation

Interventions

DRUG

Remifentanyl

Start dose:9 µg/kg/h Maximum dose: 30 µg/kg/h

DRUG

Fentanyl

start dose: 3 µg/kg/h Maximum dose: 10 µg/kg/h

Trial Locations (1)

50937

Clinic for Paediatrics, University of Cologne Kerpener Str. 62, Cologne

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Cologne

OTHER